127 related articles for article (PubMed ID: 38861561)
1. Continuous co-prescription of rebamipide prevents upper gastrointestinal bleeding in NSAID use for orthopaedic conditions: A nested case-control study using the LIFE Study database.
Yamate S; Ishiguro C; Fukuda H; Hamai S; Nakashima Y
PLoS One; 2024; 19(6):e0305320. PubMed ID: 38861561
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users.
Kim TJ; Kim ER; Hong SN; Kim YH; Lee YC; Kim HS; Kim K; Chang DK
Sci Rep; 2019 Aug; 9(1):11696. PubMed ID: 31406189
[TBL] [Abstract][Full Text] [Related]
3. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
Kim JH; Park SH; Cho CS; Lee ST; Yoo WH; Kim SK; Kang YM; Rew JS; Park YW; Lee SK; Lee YC; Park W; Lee DH
Gut Liver; 2014 Jul; 8(4):371-9. PubMed ID: 25071901
[TBL] [Abstract][Full Text] [Related]
4. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal anti-inflammatory drugs.
Helin-Salmivaara A; Huupponen R; Virtanen A; Lammela J; Klaukka T
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):425-31. PubMed ID: 15952021
[TBL] [Abstract][Full Text] [Related]
5. Factors Related to the Use of Topical vs. Oral NSAIDs for Sprains, Strains, and Contusions in a Senior Population: A Retrospective Analysis of Administrative Claims Data.
Sheer R; Schwab P; Essex MN; Cappelleri JC; Reiners A; Bobula J; Pasquale MK
Drugs Aging; 2018 Oct; 35(10):937-950. PubMed ID: 30203313
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for small bowel bleeding in chronic nonsteroidal anti-inflammatory drug users.
Cho KM; Park SY; Chung JO; Jun CH; Kim TJ; Son DJ; Kim BS; Park CH; Kim HS; Choi SK; Rew JS
J Dig Dis; 2015 Sep; 16(9):499-504. PubMed ID: 26147360
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.
Kurokawa S; Katsuki S; Fujita T; Saitoh Y; Ohta H; Nishikawa K; Sato Y; Sato Y; Ohira K; Yamada M; Kato M
J Gastroenterol; 2014 Feb; 49(2):239-44. PubMed ID: 23595613
[TBL] [Abstract][Full Text] [Related]
8. Effect of rebamipide on gastric ulcer healing caused by Helicobacter pylori and/or NSAIDs or non NSAIDs-non H. pylori.
Thong-Ngam D; Chayanupatkul M; Klaikeaw N; Rerknimitr R; Mahachai V
J Med Assoc Thai; 2009 Sep; 92(9):1207-12. PubMed ID: 19772181
[TBL] [Abstract][Full Text] [Related]
9. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
Etminan M; Lévesque L; Fitzgerald JM; Brophy JM
Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582
[TBL] [Abstract][Full Text] [Related]
10. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of rebamipide on NSAID-induced lower gastrointestinal tract injury using FAERS and JADER.
Imai T; Hazama K; Kosuge Y; Suzuki S; Ootsuka S
Sci Rep; 2022 Feb; 12(1):2631. PubMed ID: 35173236
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: a systematic review and meta-analysis.
Zhang S; Qing Q; Bai Y; Mao H; Zhu W; Chen Q; Zhang Y; Chen Y
Dig Dis Sci; 2013 Jul; 58(7):1991-2000. PubMed ID: 23456504
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases.
van Soest EM; Valkhoff VE; Mazzaglia G; Schade R; Molokhia M; Goldstein JL; Hernández-Díaz S; Trifirò G; Dieleman JP; Kuipers EJ; Sturkenboom MC
Gut; 2011 Dec; 60(12):1650-9. PubMed ID: 21636644
[TBL] [Abstract][Full Text] [Related]
14. Association between adherence to concomitant proton pump inhibitor therapy in current NSAID users and upper gastrointestinal complications.
Jonasson C; Hatlebakk JG; Lundell L; Kouri JP; Andersen M; Granath F
Eur J Gastroenterol Hepatol; 2013 May; 25(5):531-8. PubMed ID: 23269097
[TBL] [Abstract][Full Text] [Related]
15. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control study in a new general practice database.
de Abajo FJ; Gil MJ; Bryant V; Timoner J; Oliva B; García-Rodríguez LA
Eur J Clin Pharmacol; 2013 Mar; 69(3):691-701. PubMed ID: 22955795
[TBL] [Abstract][Full Text] [Related]
16. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.
Sugisaki N; Iwakiri R; Tsuruoka N; Sakata Y; Shimoda R; Fujimoto S; Eguchi Y; Fujimoto K
J Gastroenterol; 2018 Dec; 53(12):1253-1260. PubMed ID: 29948304
[TBL] [Abstract][Full Text] [Related]
17. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
[TBL] [Abstract][Full Text] [Related]
18. Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy).
Yamao J; Kikuchi E; Matsumoto M; Nakayama M; Ann T; Kojima H; Mitoro A; Yoshida M; Yoshikawa M; Yajima H; Miyauchi Y; Ono H; Akiyama K; Sakurai G; Kinoshita Y; Haruma K; Takakura Y; Fukui H
J Gastroenterol; 2006 Dec; 41(12):1178-85. PubMed ID: 17287897
[TBL] [Abstract][Full Text] [Related]
19. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drug related upper gastrointestinal bleeding: types of drug use and patient profiles in real clinical practice.
Sostres C; Carrera-Lasfuentes P; Lanas A
Curr Med Res Opin; 2017 Oct; 33(10):1815-1820. PubMed ID: 28569554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
